Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) EBT Margin (2016 - 2025)

Mimedx's EBT Margin history spans 15 years, with the latest figure at 18.45% for Q4 2025.

  • For Q4 2025, EBT Margin rose 635.0% year-over-year to 18.45%; the TTM value through Dec 2025 reached 15.83%, down 59.0%, while the annual FY2025 figure was 15.83%, 59.0% down from the prior year.
  • EBT Margin for Q4 2025 was 18.45% at Mimedx, down from 20.09% in the prior quarter.
  • Across five years, EBT Margin topped out at 26.62% in Q2 2024 and bottomed at 17.7% in Q1 2022.
  • The 5-year median for EBT Margin is 10.65% (2023), against an average of 5.05%.
  • The largest annual shift saw EBT Margin surged 2691bps in 2021 before it plummeted -1354bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 0.18% in 2021, then skyrocketed by 7301bps to 13.25% in 2022, then increased by 21bps to 16.02% in 2023, then decreased by -24bps to 12.11% in 2024, then surged by 52bps to 18.45% in 2025.
  • Per Business Quant, the three most recent readings for MDXG's EBT Margin are 18.45% (Q4 2025), 20.09% (Q3 2025), and 13.19% (Q2 2025).